Clinical Trial

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

Study acronym: EPPIC
Recruiting
View on ClinicalTrials.gov →
Summary
The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2021-11-16; most recent amendment 2026-01-22.
Status change: Not Yet Recruiting → Recruiting 2022-08-22
Trial Details
NCT Number NCT05127616
Lead Sponsor State University of New York at Buffalo
Collaborators: University of California, Los Angeles, University of Michigan
Conditions Urologic Chronic Pelvic Pain Syndrome (UCPPS), Interstitial Cystitis, Bladder Pain Syndrome, Chronic Prostatitis, Chronic Pain, Chronic Pelvic Pain Syndrome, Chronic Overlapping Pain Disorders
Enrollment 240 participants
Start Date 2022-08-10
Primary Completion 2028-02 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-26